Purinergic Signalling

James Wiley

Principal Research Fellow

MD (Syd), FRACP, FRCPA

james.wiley@florey.edu.au

 

Research Focus

The Purinergic Signalling laboratory looks at the role of purinergic P2X receptors and their polymorphic variants in various inflammatory and degenerative conditions affecting the brain.

Under certain conditions P2X receptors act like scavenger receptors which quietly remove apoptotic cells while under other conditions these receptors may stimulate neuroinflammation and be associated with disease states. Activation of P2X7 receptors may also lead to oxidative stress and contribute to the extent of damage following brain trauma.

Current Projects

Neurodegeneration; neurotrauma

Technical Expertise

Flow cytometry; hematology; molecular biology; human genetics

Funding

Leukemia Foundation of Australia

Collaborators

Australia and New Zealand Multiple Sclerosis Genetics Consortium

Steven Petrou

Back to Research Groups